# Gerald B. Appel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gerald-b-appel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,008 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 89 |
| i10-index | 223 |
| Last Known Institution | NewYork–Presbyterian Hospital |
| OpenAlex ID | https://openalex.org/A5113906923 |
| Works | 347 |

## Researcher papers

Showing 12 of 35.

- [The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited](https://scholariq.org/papers/the-classification-of-glomerulonephritis-in-systemic-lupus-erythematosus/)
- [The classification of glomerulonephritis in systemic lupus erythematosus revisited](https://scholariq.org/papers/the-classification-of-glomerulonephritis-in-systemic-lupus-erythematosus-2/)
- [Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study](https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-patients-with-active-proliferative-lupus/)
- [Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-or-intravenous-cyclophosphamide-for-lupus-nephritis/)
- [Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus/)
- [Diagnostic Utility of Exome Sequencing for Kidney Disease](https://scholariq.org/papers/diagnostic-utility-of-exome-sequencing-for-kidney-disease/)
- [Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-and-c3-glomerulopathy-conclusions-from-a/)
- [Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-versus-azathioprine-as-maintenance-therapy-for-lupus-nephritis/)
- [C3 glomerulopathy: consensus report](https://scholariq.org/papers/c3-glomerulopathy-consensus-report/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy](https://scholariq.org/papers/randomized-trial-of-an-inhibitor-of-formation-of-advanced-glycation-end-products/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [NewYork–Presbyterian Hospital](https://scholariq.org/institutions/newyork-presbyterian-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.